Ebola
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living individuals as well as samples from those recently deceased who are suspected to have died from Ebola.
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo.
The World Health Organization recently deployed a rapid response team and personal protective equipment to the United Republic of Tanzania following unofficial reports of two suspected cases of Ebola virus disease in the African nation.
One year after the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola, the situation has improved, but the outbreak continues.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce additional doses of its investigational Ebola vaccine over the next year as part of the international response to the outbreak in the Democratic…
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those receiving two other treatments as part of the clinical trial.
One year after the Democratic Republic of the Congo declared an outbreak of Ebola, the outbreak continues in North Kivu and Ituri provinces, with 2,698 cases and 1,813 deaths to date.
The Centers for Disease Control and Prevention is working with the U.S. Embassy in the Democratic Republic of the Congo to preposition staff in Goma to rapidly identify Ebola cases and prevent further spread of the disease in hotspots where the security situation permits.
The World Health Organization today declared the Ebola virus disease outbreak in the Democratic Republic of the Congo a public health emergency of international concern.
Two investigational Ebola treatments being used in the ongoing outbreak in the Democratic Republic of the Congo are effective in laboratory studies.